Understanding these interactions could provide insights into the metabolic and inflammatory crosstalk between adipose tissue and the liver plus exploring how PXR, ERα, NRF2, and AhR pathways interact with estrogen signaling will both provide critical insights into therapeutic approaches for ALD and related liver disorders. Here, NR1I2 is linked to liver disorder.